The DOI matches its Crossref record.
Excerpts From the US Renal Data System 2009 Annual Data Report
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cited by
Sorted by citations
Items 201–300 of 436
Atakan, A., Macunluoğlu, B., Kaya, Y., Arı, E., Demir, H., Aşıcıoğlu, E., & Kaspar, Ç. (2013) · Biological Trace Element Research · doi:10.1007/s12011-013-9803-8 · Cited by 15
Treatment outcomes for ischemic heart disease in dialysis-dependent patients
Yeates, A., Hawley, C. M., Mundy, J. A., et al. (2012) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492312437383 · Cited by 15
“The life expectancy of patients with ESRD has improved since the invention of dialysis in the 1960s.(9) However, the survival of dialysis patients is well below that of the general population.”
BackgroundFocal Ablative Therapy for Renal Cell Carcinoma in Transplant Allograft Kidneys
Gul, Z., Griffith, J. J., Welch, C., et al. (2018) · Urology · doi:10.1016/j.urology.2018.12.003 · Cited by 15
Dolla, C., Naso, E., Mella, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78938-3 · Cited by 15
Characteristics and mortality determinants of COVID-19 patients undergoing hemodialysis
Sipahi, S., Dheir, H., Toçoğlu, A. G., et al. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2006-54 · Cited by 14
“Infections are the second most common cause of death, following cardiovascular diseases [3].”
BackgroundFerrantelli, E., Liappas, G., Keuning, E. D., et al. (2015) · BioMed Research International · doi:10.1155/2015/106902 · Cited by 14
Alteration of Type I Collagen in the Radial Artery of Patients With End-Stage Renal Disease
Bai, Y., Zhang, J., Xu, J., et al. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000408 · Cited by 14
“The incidence of CVD in patients with CKD exceeds that of the normal population by 20- to 30fold.(1,2) Traditional risk factors for CKD such as hypertension, smoking, diabetes and lipid metabolism disorders cannot fully explain the high incidence of CVD, also CKD is in itself a type of vascular disease and is an indep…”
BackgroundShaheed, C. A., Carland, J. E., Graham, G. G., STOCKER, S. L., Smith, G., Hicks, M., Williams, K. M., Furlong, T. J., Macdonald, P. S., Greenfield, J. R., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14107 · Cited by 14
“%) in the ERA-EDTA registry,24 as well as renal registries in the Asia Pacific46 and North America.47 Whilst 3 studies were carried out in the Middle East,29,30,41 a country-specific consideration of these figures was not possible as mortality has not been reported in renal registries in the Middle East.51 However, th…”
ResultEstimated prevalence of childhood end-stage renal disease in the state of São Paulo
Nogueira, P. C. K., Feltran, L. D. S., de Camargo, M. F. C., et al. (2011) · Revista da Associação Médica Brasileira · doi:10.1016/s0104-4230(11)70091-4 · Cited by 13
Investigating the pathogenesis and risk of Type 2 diabetes: clinical applications of metabolomics
Ng, T. W., Khan, A. A., & Meikle, P. J. (2012) · Clinical Lipidology · doi:10.2217/clp.12.75 · Cited by 14
Dhaybi, O. A., & Bakris, G. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.758 · Cited by 12
“BETA BLOCKERS Cardiovascular disease is the major cause of death in patients with advanced kidney failure.(39) Approximately 29.”
BackgroundChan, K., Chen, Y., Lit, Y., Massaband, P., Kiratli, B. J., Rabkin, R., & MYERS, J. N. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100365 · Cited by 12
Moreels, T., VELDE, D. V. D., Duyse, S. V., Wyngaert, K. V., Leune, T., Biesen, W. V., & VRIENDT, P. D. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad104 · Cited by 20
Sipahioğlu, M. H., Usvyat, L. A., Liu, L., et al. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000342634 · Cited by 12
Direct imaging of APP proteolysis in living cells
Parenti, N., Grosso, A. D., Antoni, C., Cecchini, M. G., Corradetti, R., Pavone, F. S., & Calamai, M. (2017) · PeerJ · doi:10.7717/peerj.3086 · Cited by 13
Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome
Königshausen, E., & Sellin, L. K. (2017) · BioMed Research International · doi:10.1155/2017/7689254 · Cited by 12
Inampudi, C., Akintoye, E. O., Jayanna, M. B., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.02.020 · Cited by 12
Prevalence of diabetic kidney disease in prediabetes
Branda, J. I. F., de Almeida-Pititto, B., & Ferreira, S. R. G. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100105 · Cited by 12
Measures of blood pressure and cognition in dialysis patients
Giang, L. M., Tighiouart, H., Lou, K. V., Agganis, B. T., Drew, D. A., Shaffi, S. K., Scott, T. M., Weiner, D. E., & Sarnak, M. J. (2012) · Hemodialysis International · doi:10.1111/j.1542-4758.2012.00718.x · Cited by 12
The long-term outcome after acute kidney injury: a narrative review
Pôncio, L., Balbi, A. L., da Rocha, É. P., et al. (2015) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20150016 · Cited by 12
Lee, T. C., Thamer, M., Zhang, Q., et al. (2016) · American Journal of Nephrology · doi:10.1159/000446159 · Cited by 11
Icodextrin reduces the risk of congestive heart failure in peritoneal dialysis patients
Wang, I., Lin, C., Yen, T., et al. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4412 · Cited by 11
“Cardiovascular disease is the major cause of mortality in patients with end‐stage renal disease (ESRD).(1,2) Fluid overload, hypertension, and atherosclerosis are the major underlying mechanisms leading to the development of cardiovascular disease in ESRD patients.”
BackgroundKhan, A. H. K. Y., Zakaria, N. F., Abidin, M. A. Z., & Kamaruddin, N. A. (2021) · Medicine · doi:10.1097/md.0000000000026729 · Cited by 12
“Type 2 diabetes mellitus (T2DM) is the primary cause of endstage kidney disease (ESKD) worldwide.([1,2]) A similar trend is seen inMalaysia, where the prevalence of ESKDhas doubled over the last 10 years, with almost two-thirds of patients having diabetes.”
BackgroundThe Risk of Septicemia in End-Stage Renal Disease With and Without Renal Transplantation
Shen, T., Wang, I., Wei, C., et al. (2015) · Medicine · doi:10.1097/md.0000000000001437 · Cited by 11
“Septicemia is one of the most severe type of infection in ESRD patients.(2) The mortality rate in uremic patients with septicemia was between 12% and 22%.”
BackgroundWan, S., Slusser, J. P., Hodge, D. O., et al. (2018) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2018.01.003 · Cited by 11
“Chronic hypertension detrimentally affects kidney function, and hypertension leading to end-stage renal disease has been extensively studied.(7) The pathophysiology includes renal vasculature remodeling and dysregulation of the renin-angiotensin-aldosterone pathway.”
BackgroundClinical Approach to the Diagnosis of Acute Kidney Injury
Macedo, E. M., & Mehta, R. L. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4617-0.00033-9 · Cited by 11
Park, S., Kim, Y., Jo, H. A., Lee, S., Kim, M., Yang, B. R., Lee, J., Han, S. S., Lee, H., Lee, J. P., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa037 · Cited by 11
Westervelt, J. D., Alexander, B. D., Costa, S. F., et al. (2012) · Clinical Transplantation · doi:10.1111/ctr.12048 · Cited by 11
“The emergence of BK polyomavirus (BKV) infection over the past decade may be a contributing factor to this phenomenon (4, 5).”
BackgroundOlsen, G. W., Andres, K. L., Johnson, R. A., et al. (2012) · Journal of Occupational and Environmental Hygiene · doi:10.1080/15459624.2012.667349 · Cited by 11
Self-citationWu, C., Wu, C., Lin, C., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017035 · Cited by 11
“As reported in the US Renal Data System 2009 annual data report, survival decreased with age, and HD patients with diabetes had poorer survival at 10 years compared with those without diabetes.(20) Hypoalbuminaemia, hypokalaemia, hypophosphataemia and low parathyroid hormone levels are associated with malnutrition and…”
ResultEncapsulating Peritoneal Sclerosis in Long-Termed Peritoneal Dialysis Patients
Hsu, H.-J., Yang, S., Wu, I., et al. (2018) · BioMed Research International · doi:10.1155/2018/8250589 · Cited by 11
“In addition to the huge cost of ESRD management, patients who suffer from ESRD also experience a decreased quality of life [4, 5] and lifespan [6].”
BackgroundRole of UPP pathway in amelioration of diabetes-associated complications
Gupta, A. K., Behl, T., Aleya, L., Rahman, M. H., Yadav, H. N., Pal, G., Kaur, I., & Arora, S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-12781-5 · Cited by 11
Mambelli, E., Grandi, F., & Santoro, A. (2024) · Journal of Nephrology · doi:10.1007/s40620-023-01844-0 · Cited by 10
“This complication is even more evident because the mean age of the dialytic population is increasing, along with the increasing frequency of comorbidities such as diabetes and underlying cardiac disease [1].”
BackgroundKhan, A. H. K. Y., Zakaria, N. F., Abidin, M. A. Z., Lim, C. T. S., & Kamaruddin, N. A. (2020) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.035.01.12 · Cited by 11
Wu, Y. J., Huang, B., Zhang, W., et al. (2022) · Journal of International Medical Research · doi:10.1177/03000605221088557 · Cited by 10
“According to an annual report by the USRDS, cardiovascular events and infection are the most common causes of death among patients undergoing MHD.(11) In addition, Ali and colleagues showed that cardiovascular events, infection, and malignancy are the leading causes of the mortality in patients commencing MHD.”
MethodNasution, A., Sulaiman, S. A. S., & Shafie, A. A. (2013) · Value in Health Regional Issues · doi:10.1016/j.vhri.2013.02.009 · Cited by 10
“One of its common complications is infection, which is the second leading cause of death of patients with CKD, especially those in stages 4 and 5 [7,8].”
BackgroundThe effect of vibration on the severity of restless legs syndrome in hemodialysis patients
Hosseini, H., Kazemi, M., & Azimpour, S. (2016) · Journal of Renal Injury Prevention · doi:10.15171/jrip.2017.22 · Cited by 10
“Regarding the point that diabetes and hypertension are the underlying diseases that lead to the emergence of ESRD, and that the incidence of these conditions increases with age (13).”
BackgroundLiu, X., Mao, Y., He, X., et al. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.216412 · Cited by 10
“[3] Researchers are able to find the main factors that affect the development and changing trends of the original sequence of the system in which the influencing factors are yet to be clarified through the method.[4] It shares the advantages of the unlimitedness of sample sizes, the explicitness of principles, the ext…”
BackgroundChen, S., Lee, C., & Kuo, H. (2018) · LUTS Lower Urinary Tract Symptoms · doi:10.1111/luts.12240 · Cited by 10
“CKD is highly prevalent in patients with diabetes, hypertension, and glomerulonephritis.(16) There-”
BackgroundSelf-citationEffect of isothermic dialysis on intradialytic hypertension
Veerappan, I., Thiruvenkadam, G., Abraham, G., et al. (2019) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_113_18 · Cited by 10
Tsujikawa, H., Tanaka, S., Matsukuma, Y., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213922 · Cited by 10
Hu, K., Peng, H., Ma, Y., Li, X., Bai, R., Wang, J., Xu, J., Fu, L., Liu, J., Bai, J., et al. (2021) · Blood Purification · doi:10.1159/000513162 · Cited by 10
Self-citationGutzwiller, F. S., Pfeil, A. M., Ademi, Z., et al. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0320-9 · Cited by 10
“5 years for those aged 60–64 years [9].”
BackgroundDialysis Patients and Critical Illness
Thompson, S., & Pannu, N. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.07.026 · Cited by 10
Hosseinpanah, F., Barzin, M., Golkashani, H. A., Nassiri, A. A., Sheikholeslami, F. H., & Azizi, F. (2012) · BMC Nephrology · doi:10.1186/1471-2369-13-59 · Cited by 10
Wallace, Z. S., Zhang, Y., Lu, N., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23521 · Cited by 10
“premature death (2,3), especially due to cardiovascular disease (CVD) (2,4) and infection (5,6).”
BackgroundOkazaki, M., Inaguma, D., Imaizumi, T., et al. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0859-8 · Cited by 10
“Considering the leading cause of death for patients with ESRD is CVD [10], further studies are needed to investigate the risk factors associated with mortality after dialysis in patients with late referral.”
BackgroundDopheide, J. F., Zeller, G. C., Kuhlmann, M. K., et al. (2015) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/40463 · Cited by 9
“Nevertheless, the overall 5-year survival rate for ESRD patients has improved since the early 1990s due to improved treatment and disease management [1].”
BackgroundNursing educational intervention for the identification of Adverse Events in hemodialysis
Pássaro, P. G., & D’Ávila, R. (2018) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2017-0843 · Cited by 9
Qureshi, A. R., Evans, M., Stendahl, M., et al. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sft032 · Cited by 9
“The RRT incidence is routinely collected by renal registries in many countries and shows a 45-fold variation across the world [5].”
BackgroundSchneider, A., Schneider, M. P., Krieter, D. H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128079 · Cited by 9
“Despite efforts to improve outcomes in patients with end-stage renal disease (ESRD), mortality remains excessively high [1].”
Backgroundde Almeida, L. L. S., Sette, L. H. B. C., Fonseca, F. L. A., et al. (2019) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2018-0171 · Cited by 9
Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer
Pan, S., Smith, A. D., & Motamedinia, P. (2017) · Journal of Endourology · doi:10.1089/end.2016.0475 · Cited by 8
Liu, X., Mao, Y.-H., Wang, H. T., et al. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.221266 · Cited by 8
“Due to the high consumption of medical resources as well as the repeatability in treatment, families of CKD patients are bearing huge economic burdens, and the problem has already become a serious social issue in health management and economics.[2] Path Analysis on Medical Expenditures of 855 Patients with Chronic Kid…”
BackgroundUtility of muscle ultrasound in nutritional assessment of children with nephrotic syndrome
Gehad, M. H., Yousif, Y. M., Metwally, M. I., AbdAllah, A., Elhawy, L. L., El‐Shal, A. S., & Abdellatif, G. M. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05776-y · Cited by 8
Long-Term Effects of Kidney Donation on Renal Function and Blood Pressure in African Americans
Budisavljevic, M. N., Nietert, P. J., Zhai, Y., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08240910 · Cited by 8
A protocol for rat kidney normothermic machine perfusion and subsequent transplantation
Czogalla, J., Grahammer, F., Puelles, V. G., & Huber, T. B. (2020) · Artificial Organs · doi:10.1111/aor.13799 · Cited by 9
An Update on Drug-eluting Technology in Peripheral Arteries to Treat Peripheral Arterial Disease
Marques, L., Hopf-Jensen, S., Preiß, M., et al. (2021) · Heart International · doi:10.17925/hi.2021.15.2.73 · Cited by 8
Phosphate-Induced Apoptosis in Human Peritoneal Mesothelial Cells in vitro
Park, J., Yook, J.-M., Ryu, H., et al. (2011) · American Journal of Nephrology · doi:10.1159/000329081 · Cited by 8
Ennezat, P. V., Vanesson, C., Bouabdallaoui, N., Maréchaux, S., Asseman, P., & LeJemtel, T. H. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.543675 · Cited by 8
“Diabetes mellitus is a major cause of cardiovascular events and renal disease [48].”
BackgroundJeong, H. Y., Cho, H. J., Kim, S. H., Kim, J. C., Lee, M. J., Yang, D. H., & Lee, S. (2017) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2017.36.3.282 · Cited by 8
Driver, C., Hayangah, J. A., Nyane, N. A., & Owira, P. M. O. (2017) · Journal of Nephropathology · doi:10.15171/jnp.2018.37 · Cited by 8
“Diabetes is the most common cause of impairment of renal function leading to end-stage renal disease and increased risk of morbidity and mortality (42-44).”
BackgroundConsiderations for the clinical use of stem cells in genitourinary regenerative medicine
Caneparo, C., Sorroza-Martinez, L., Chabaud, S., Fradette, J., & Bolduc, S. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i10.1480 · Cited by 8
Relationship between Fetuin-A and vascular or valvular calcification in hemodialysis patients
Ossareh, S., Marghoob, B., & Robabeh, B. (2019) · Journal of Clinical Nephrology · doi:10.29328/journal.jcn.1001021 · Cited by 8
“The high prevalence of cardiovascular events in ESKD patients is associated with traditional risk factors including hypertension, dyslipidemia, diabetes mellitus, and smoking.”
BackgroundInfluentialWang, J., Zhao, J., Li, L., Lin, X., Guo, X., Peng, F., Zuo, X., Liu, X., & Ying, C. (2024) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2024.05.005 · Cited by 7
Comparison of Turkish and US haemodialysis patient mortality rates: an observational cohort study
Aşçı, G., Marcelli, D., Çeltik, A., et al. (2016) · Clinical Kidney Journal · doi:10.1093/ckj/sfw027 · Cited by 7
“There was a large difference in the proportion of patients dialysed with AV fistula between the two cohorts, which is associated with better survival rates compared with AV graft or catheter: 86% in this cohort versus 55% in USRDS report [1].”
BackgroundResultLi, M., Li, Y., Lv, J., et al. (2021) · Perfusion · doi:10.1177/02676591211042726 · Cited by 7
“Exclusion criteria: (1) pregnant, nursing, or planning for pregnancy; (2) Hb ⩽ 60 g/L or WBC ⩾ 10.”
What is the Difference between Causes of ESRD in Iran and Developing Countries
Mousavi, S. S. B., Hayati, F., & Mousavi, M. (2012) · Shiraz E-Medical Journal · Cited by 7
Lee, I. S., Lee, J. H., Kim, H. J., Lee, J. M., Lee, S., Kim, H. S., Lee, J. M., Park, K. S., & Ku, B. J. (2013) · Europe PMC (PubMed Central) · doi:10.3233/dma-120949 · Cited by 7
“Diabetes is the most common cause of end-stage renal failure, accounting for 35%–40% of all new cases requiring dialysis therapy throughout the world [26].”
BackgroundJain, N., & Reilly, R. F. (2016) · Seminars in Dialysis · doi:10.1111/sdi.12484 · Cited by 7
“Cardiovascular (CV) disease accounts for about half of all deaths in the hemodialysis (HD) population (1,2).”
BackgroundSGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus
Gill, A., Gray, S. P., Jandeleit-Dahm, K. A. M., & Watson, A. M. D. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180417121246 · Cited by 8
Cardiac MRI assessment of the right ventricle pre-and post-kidney transplant
Hashi, A. A., Prasad, G. V. R., Connelly, P. W., Deva, D. P., Nash, M. M., Yuan, W., Wald, R. M., Wald, R., Gunaratnam, L., Lok, C. E., et al. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-020-02153-4 · Cited by 7
Rodriguez‐Fernandez, R., Infante, O., Perez‐Grovas, H., Hernandez, E., Ruiz‐Palacios, P., Franco, M., & Lerma, C. (2012) · Artificial Organs · doi:10.1111/j.1525-1594.2011.01382.x · Cited by 6
Study of the incidence of dialysis in São Paulo, the largest Brazilian city
Cordeiro, A. C., Carrero, J. J., Qureshi, A. R., et al. (2013) · Clinics · doi:10.6061/clinics/2013(06)06 · Cited by 6
“prevalence in South Korea (7), and the incidence rates of patients starting RRT have been reported as decreasing in the USA in recent years (8,9) and stabilizing in Europe (10).”
BackgroundResultInfluentialShu, H., Tai, Y., Chang, K., Chu, C., Hsu, P., Su, H., Lin, T., Voon, W., Lai, W., & Sheu, S. (2015) · Europe PMC (PubMed Central) · doi:10.6515/acs20140630c · Cited by 6
Relationship between Intra-renal Arterial Resistance Index (RI) and Albuminuria in Diabetic Patients
Mahmoud, F., Reza, N. M., & Nader, N. M. (2012) · Iranian journal of diabetes and obesity · Cited by 6
Timing of Dialysis Initiation and Mortality Risk in Chronic Kidney Disease: A Meta‐Analysis
Zhao, Y., Pei, X., & Zhao, W. (2018) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12721 · Cited by 6
“According to the United States Renal Data System, people over 65 years of age comprise the most rapidly increasing ESRD population in United States (35).”
MethodInfluentialKarimi, Z., Shahraki, H. R., & Mohammadian-Hafshejani, A. (2023) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2023.200220 · Cited by 6
“In the United States, the average survival time on dialysis is eight years for individuals aged 40 – 44 and 4.5 years for those aged 60 – 64 [8].”
BackgroundInfluentialTherapeutic Potential for CD39 in Renal Transplantation: There Is Hope
Laubach, V. E. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03300.x · Cited by 6
“The number of patients on the kidney transplant wait list continues to increase and wait times are also increasing nationwide (1).”
BackgroundResultInfluentialMore Frequent Hemodialysis: What Do We Know? Where Do We Stand?
Raimann, J. G., Thijssen, S., Ramos, R., et al. (2011) · Contributions to nephrology · doi:10.1159/000327331 · Cited by 6
P ‐selectin, E ‐selectin, and CD40L over time in chronic hemodialysis patients
Bossola, M., Rosa, F., Tazza, L., et al. (2011) · Hemodialysis International · doi:10.1111/j.1542-4758.2011.00579.x · Cited by 6
Vijayan, A., Franklin, S. C., Delmez, J. A., et al. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70322-2 · Cited by 6
Urinary Diversion via Cutaneous Vesicostomy in the Megabladder Mouse
Carpenter, A. R., Becknell, B., Hirselj, D. A., et al. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-851-1_34 · Cited by 6
Johnson, L. A., Rodansky, E. S., Moons, D. S., Larsen, S. D., Neubig, R. R., & Higgins, P. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw210 · Cited by 7
“19,21 Fibrosis was scored separately as follows: [0] no fibrosis; [1] mild fibrosis [focal mucosal/submucosal collagen deposition without architectural distortion]; [2] moderate fibrosis [significant mucosal/submucosal collagen deposition with modest distortion of mucosal/submucosal architecture but without obscuring…”
BackgroundMethodRevascularization as a treatment to improve renal function
Kalra, P. A., Alderson, H. V., & Ritchie, J. P. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s35633 · Cited by 6
Chiou, S., Kung, P., Naessens, J. M., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.07.004 · Cited by 6
“[17] Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, et al.”
BackgroundIncidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study
O’Lone, E., Kelly, P. J., Masson, P., Kotwal, S. S., Gallagher, M., Cass, A., Craig, J. C., & Webster, A. C. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.03.002 · Cited by 6
Mortality of dialysis patients in Qatar: A retrospective epidemiologic study.
Ghonimi, T. A. L., Hamad, A., Iqbal, Z., et al. (2021) · PubMed · doi:10.5339/qmj.2020.02 · Cited by 6
Treatment Strategy for Dialysis Patient with Urothelial Carcinoma
Huang, Y., Liu, Y., Chen, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11111966 · Cited by 6
“Independent predictors of mortality in dialysis patients include comorbid conditions, underlying renal disease process, age, country, race, psychosocial factors, poor nutrition, high salt intake, and residual kidney function [36].”
BackgroundChronic Kidney Disease and Dialysis
Little, J. W., Falace, D. A., Miller, C. S., & Rhodus, N. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-323-08028-6.00012-9 · Cited by 6
Temporal muscle thickness predicts mortality in prevalent hemodialysis patients
Kara, E., Şahutoğlu, T., Demirbaş, S., et al. (2022) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220844 · Cited by 5
Age Is Just a Number for Older Kidney Transplant Patients
Quint, E. E., Pol, R. A., Segev, D. L., & McAdams‐DeMarco, M. (2024) · Transplantation · doi:10.1097/tp.0000000000005073 · Cited by 5
Okamoto, K., Shimizu, H., Ueda, T., et al. (2010) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2010.255703 · Cited by 5
Perioperative Care for Kidney Transplant Recipients
Hultin, S., Hawley, C. M., Johnson, D. W., & Francis, R. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84388 · Cited by 6
“Improvements in dialysis therapy have been accompanied by a decline in mortality rate [3].”
BackgroundCharlson Comorbidity Index as a Strong Predictor of Mortality in Patients with Chronic Hemodialysis
Soleymanian, T., Ghaziani, Z. M., & تهران, د. ع. پ. (2018) · مجله پزشکی بالینی ابن سینا · doi:10.21859/ajcm.25.3.151 · Cited by 5
Jawale, C. V., Li, D., Ramani, K., Lin, L., Li, K., Methé, B. A., & Biswas, P. S. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2000114 · Cited by 5
Shimels, T., Getachew, A., Siyoum, M. T., & Thompson, A. K. (2021) · Health Services Research and Managerial Epidemiology · doi:10.1177/23333928211018335 · Cited by 5
Trends of medication used in patients with pre-ESKD from 2010 to 2018 in Taiwan
Lin, C., Chien, M.-H., Yang, M.-J., et al. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.12.012 · Cited by 5
Atherosclerotic Renovascular Disease: Epidemiology and Clinical Manifestations
Ritchie, J. P., & Kalra, P. A. (2014) · Springer eBooks · doi:10.1007/978-1-4471-2810-6_1 · Cited by 5
Exercise Training for Individuals with Advanced Chronic Kidney Disease
Storer, T. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00045-x · Cited by 5
Metadata
- Authors
- Collins, A. J., Foley, R. N., Herzog, C., Chavers, B. M., Gilbertson, D., Ishani, A., Kasiske, B. L., Liu, J., Mau, L.-W., McBean, M., Murray, A., St. Peter, W., Guo, H., Li, Q., Li, S., Li, S., Peng, Y., Qiu, Y., Roberts, T., Skeans, M., Snyder, J., Solid, C., Wang, C., Weinhandl, E., Zaun, D., Arko, C., Chen, S.-C., Dalleska, F., Daniels, F., Dunning, S., Ebben, J., Frazier, E., Hanzlik, C., Johnson, R., Sheets, D., Wang, X., Forrest, B., Constantini, E., Everson, S., Eggers, P. W., & Agodoa, L.
- Affiliations
- United States Department of Veterans Affairs (US)
- ORCID
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 55
- Issue
- 1
- Pages
- A6-A7
- ISSN
- 0272-6386 (ISSN-L)
- PMC
- PMC2829836
- OpenAlex
- W1955298113
- Cited by
- 436
- References
- 0
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 12 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 20 · 2019: 23 · 2018: 35 · 2017: 25 · 2016: 34 · 2015: 40 · 2014: 29 · 2013: 42 · 2012: 37
- FWCI
- 19.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Kidney Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (HHSN 267 2007 15002C/N01-DK-7-5002, HHSN267200715002C)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, end-stage renal disease, acute kidney injury, mortality risk, blood pressure control, lipid control, health care costs, morbidity, NHANES
- MeSH terms
- Chronic Disease, Medicare, Renal Dialysis, Humans, Kidney Diseases, United States, Kidney Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
